Tapewire

Nasdaq · USD

ONC

BeOne Medicines Ltd.

Export transactions ↓
Tapewire entity
2168
SEC CIK
0001651308
Parsed reports
543

Last 12 months

Inside the activity.

0 purchase rows · 204 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025017
Dec 2025026
Jan 202601
Feb 202602
Mar 202601
Apr 202601
May 202608
Jun 2026032
Jul 2026064
Aug 2026027
Sep 2026020
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 05, 2024 Filed Jun 7, 2024 21:05 UTC
Ball Titus B.Principal Accounting Officer
GrantShare Option (Right to Buy) · Derivative 15,340 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000069 · wk-form4_1717794316.xml · derivative · entry 2

Ball Titus B. · CIK 0001675628 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,340

Underlying: Ordinary Shares · 15,340 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:05 UTC
Ball Titus B.Principal Accounting Officer
GrantOrdinary Shares 24,427 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000069 · wk-form4_1717794316.xml · nonDerivative · entry 1

Ball Titus B. · CIK 0001675628 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,905

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:01 UTC GrantShare Option (Right to Buy) · Derivative 34,151 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000064 · wk-form4_1717794089.xml · derivative · entry 2

BRANDICOURT OLIVIER · CIK 0001508518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,151

Underlying: Ordinary Shares · 34,151 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:01 UTC GrantOrdinary Shares 16,341 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000064 · wk-form4_1717794089.xml · nonDerivative · entry 1

BRANDICOURT OLIVIER · CIK 0001508518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,341

F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:00 UTC GrantShare Option (Right to Buy) · Derivative 34,151 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000063 · wk-form4_1717794032.xml · derivative · entry 2

HOOPER ANTHONY C · CIK 0001277244 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,151

Underlying: Ordinary Shares · 34,151 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:00 UTC GrantOrdinary Shares 16,341 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000063 · wk-form4_1717794032.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,755

F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:04 UTC
Wu XiaobinPresident, COO & GM China
GrantShare Option (Right to Buy) · Derivative 477,386 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000068 · wk-form4_1717794275.xml · derivative · entry 5

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 477,386

Underlying: Ordinary Shares · 477,386 shares

Expires 2034-06-04

F7 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F7 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.

F8 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:04 UTC
Wu XiaobinPresident, COO & GM China
GrantOrdinary Shares 253,409 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000068 · wk-form4_1717794275.xml · nonDerivative · entry 1

Wu Xiaobin · CIK 0001739452 · President, COO & GM China

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,268,849

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

F2 · balance_after: Includes 1,443 ordinary shares acquired pursuant to the Company's Third Amended and Restated 2018 Employee Share Purchase Plan.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:02 UTC GrantShare Option (Right to Buy) · Derivative 34,151 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000065 · wk-form4_1717794139.xml · derivative · entry 2

Dugan Margaret · CIK 0001909734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,151

Underlying: Ordinary Shares · 34,151 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 21:02 UTC GrantOrdinary Shares 16,341 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000065 · wk-form4_1717794139.xml · nonDerivative · entry 1

Dugan Margaret · CIK 0001909734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,955

F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:58 UTC GrantShare Option (Right to Buy) · Derivative 34,151 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000060 · wk-form4_1717793874.xml · derivative · entry 2

Glazer Donald W. · CIK 0001660940 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,151

Underlying: Ordinary Shares · 34,151 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:58 UTC GrantOrdinary Shares 16,341 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000060 · wk-form4_1717793874.xml · nonDerivative · entry 1

Glazer Donald W. · CIK 0001660940 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,718,464

F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:57 UTC GrantShare Option (Right to Buy) · Derivative 34,151 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000059 · wk-form4_1717793831.xml · derivative · entry 2

Riva Alessandro · CIK 0001867172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,151

Underlying: Ordinary Shares · 34,151 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:57 UTC GrantOrdinary Shares 16,341 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000059 · wk-form4_1717793831.xml · nonDerivative · entry 1

Riva Alessandro · CIK 0001867172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,955

F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:56 UTC
Wang XiaodongDirector · Chair, Scientific Advisory Brd
GrantShare Option (Right to Buy) · Derivative 410,657 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000058 · wk-form4_1717793771.xml · derivative · entry 5

Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,657

Underlying: Ordinary Shares · 410,657 shares

Expires 2034-06-04

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F5 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:56 UTC
Wang XiaodongDirector · Chair, Scientific Advisory Brd
GrantOrdinary Shares 108,992 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000058 · wk-form4_1717793771.xml · nonDerivative · entry 1

Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,568,430

F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:55 UTC GrantShare Option (Right to Buy) · Derivative 34,151 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-24-000057 · wk-form4_1717793720.xml · derivative · entry 2

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,151

Underlying: Ordinary Shares · 34,151 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:55 UTC GrantOrdinary Shares 16,341 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000057 · wk-form4_1717793720.xml · nonDerivative · entry 1

Sanders Corazon (Corsee) D. · CIK 0001796536 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,241

F1 · security: Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:31 UTC
Yi QingqingDirector
GrantShare Option (Right to Buy) · Derivative 34,151 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0000902664-24-004124 · ownership.xml · derivative · entry 2

Yi Qingqing · CIK 0001662556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,151

Underlying: Ordinary Shares · 34,151 shares

Expires 2034-06-04

F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares.

F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares.

F3 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 20:31 UTC
Yi QingqingDirector
GrantOrdinary Shares 16,341 $0.00 $0.00
Disclosure

SEC source: 0000902664-24-004124 · ownership.xml · nonDerivative · entry 1

Yi Qingqing · CIK 0001662556 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,955

F1 · shares: Represents securities underlying restricted share units ("RSUs"). All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.

Read SEC document
April 11, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 2,811 $147.74 $415,306.14
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 16

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.39 to $148.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 11, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 4,265 $146.82 $626,170.24
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 15

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,811

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.39 to $147.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 11, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 5,008 $146.09 $731,608.70
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 14

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 7,076

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.39 to $146.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 60 $150.85 $9,051.00
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 13

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 12,084

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 2,641 $149.79 $395,603.58
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 12

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 12,144

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.66 to $150.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 12,501 $149.15 $1,864,572.90
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 11

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 14,785

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.66 to $149.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 10, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 11,514 $148.40 $1,708,633.85
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 10

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 27,286

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.66 to $148.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 09, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 7,924 $154.21 $1,221,947.36
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 9

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 38,800

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.88 to $154.83, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 09, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 2,734 $153.47 $419,592.45
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 8

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 46,724

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.88 to $153.87, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
April 09, 2024 Filed Apr 11, 2024 22:01 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 542 $152.28 $82,537.87
Disclosure

SEC source: 0001651308-24-000036 · wk-form4_1712872891.xml · nonDerivative · entry 7

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 49,458

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.83 to $152.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F3 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 100 $184.17 $18,417.00
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 20

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 200 $182.63 $36,525.00
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 19

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.20 to $183.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 200 $181.37 $36,273.00
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 18

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.18 to $181.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 307 $180.26 $55,339.02
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 17

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.99 to $180.40, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 993 $179.33 $178,072.31
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 16

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 807

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.87 to $179.81, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 1,801 $178.10 $320,757.20
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 15

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,800

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.69 to $178.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 5,994 $177.11 $1,061,600.94
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 14

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,601

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.69 to $177.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 2,737 $176.35 $482,663.38
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 13

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,595

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.69 to $176.64, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 12, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 200 $169.05 $33,810.00
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 12

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,332

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

Read SEC document
March 12, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 733 $166.44 $122,003.38
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 11

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,532

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.20 to $166.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 12, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 2,602 $165.49 $430,598.74
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 10

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,265

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.19 to $166.185, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 12, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 12,069 $164.49 $1,985,202.05
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 9

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,867

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.19 to $165.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 12, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 15,466 $163.78 $2,533,010.65
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 8

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,936

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.19 to $164.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 12, 2024 Filed Mar 14, 2024 21:23 UTC
OYLER JOHNDirector · Chief Executive Officer
SaleAmerican Depositary Shares 6,598 $162.74 $1,073,744.00
Disclosure

SEC source: 0001651308-24-000025 · wk-form4_1710451404.xml · nonDerivative · entry 7

OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,402

F6 · security: Each American Depositary Share represents 13 Ordinary Shares.

F7 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.19 to $163.18, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 21:04 UTC GiftOrdinary Shares 82,020 $0.00 $0.00
Disclosure

SEC source: 0001651308-24-000023 · wk-form4_1710363830.xml · nonDerivative · entry 1

Glazer Donald W. · CIK 0001660940 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,702,123

F1 · price: Bona fide gifts of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 17:22 UTC
Wang Julia AijunChief Financial Officer
SaleAmerican Depositary Shares 397 $167.08 $66,330.76
Disclosure

SEC source: 0001651308-24-000016 · wk-form4_1709590911.xml · nonDerivative · entry 2

Wang Julia Aijun · CIK 0001860279 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of February 28, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 22:24 UTC GrantShare Option (Right to Buy) · Derivative 27,794 $0.00 Strike: $12.74 $0.00
Disclosure

SEC source: 0001651308-24-000018 · wk-form4_1709591065.xml · derivative · entry 1

BRANDICOURT OLIVIER · CIK 0001508518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,794

Underlying: Ordinary Shares · 27,794 shares

Expires 2034-02-28

F1 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F1 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.

F2 · derivative.exercise_date: The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 22:44 UTC
Wang XiaodongDirector · Chair, Scientific Advisory Brd
OtherOrdinary Shares 172,372 $0.00 $0.00
Disclosure

SEC source: 0001651308-23-000167 · wk-form4_1701729842.xml · nonDerivative · entry 3

Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F3 · price: Shares held by adult child that is no longer living in reporting person's household.

F4 · ownership.nature: These securities were held in a UTMA account for the Reporting Person's child, for which the Reporting Person disclaimed beneficial ownership.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 22:44 UTC
Wang XiaodongDirector · Chair, Scientific Advisory Brd
GiftOrdinary Shares 71,890 $0.00 $0.00
Disclosure

SEC source: 0001651308-23-000167 · wk-form4_1701729842.xml · nonDerivative · entry 1

Wang Xiaodong · CIK 0001662982 · Director · Chair, Scientific Advisory Brd

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,459,438

F1 · price: Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.

Read SEC document
November 14, 2023 Filed Nov 14, 2023 22:54 UTC
BAKER BROS. ADVISORS LPDirector · 10% owner
667, L.P.Director · 10% owner
BAKER JULIANDirector · 10% owner
BAKER FELIXDirector · 10% owner
Baker Bros. Advisors (GP) LLCDirector · 10% owner
Baker Brothers Life Sciences LPDirector · 10% owner
SaleAmerican Depositary Shares 1,008,660 $180.50 $182,063,130.00
Disclosure

SEC source: 0001209191-23-055211 · doc4.xml · nonDerivative · entry 8

BAKER BROS. ADVISORS LP · CIK 0001263508 · Director · 10% owner

667, L.P. · CIK 0001551139 · Director · 10% owner

BAKER JULIAN · CIK 0001087939 · Director · 10% owner

BAKER FELIX · CIK 0001087940 · Director · 10% owner

Baker Bros. Advisors (GP) LLC · CIK 0001580575 · Director · 10% owner

Baker Brothers Life Sciences LP · CIK 0001363364 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 9,691,294

F1 · ownership.nature: American Depositary Shares ("ADS") of BeiGene, Ltd. (the "Issuer") each represent 13 Ordinary Shares ("Ordinary Shares") of the Issuer.

F5 · ownership.nature: Baker Bros. Advisors LP (the "Adviser") serves as the investment adviser to 667 and Baker Brothers Life Sciences, L.P. ("Life Sciences", and together with 667, the "Funds"). In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held directly by or held for the benefit of the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held directly by or held for the beneift of the Funds. The general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held directly by or held for the benefit of the Funds.

F6 · ownership.nature: Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by or held for the benefit of the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

F16 · ownership.nature: After giving effect to the transaction reported herein and as a result of their ownership interest in (i) Baker Brothers Life Sciences Capital, L.P. and (ii) Life Sciences, Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in the ADS reported in column 5 of Table I directly held by or held for the benefit of Life Sciences, a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC, due to their interest in Life Sciences and Baker Brothers Life Sciences Capital, L.P.'s right to receive an allocation of a portion of the profits from Life Sciences.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.